ReviewCureus2025
Hippocampal Atrophy Following Therapeutic Irradiation of Intracranial and Nasopharyngeal Tumors.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The review aims to summarize and evaluate existing data on macroscopic changes in hippocampal volume following therapeutic brain irradiation, with a focus on the patterns, dynamics, and modulating factors of this structural damage. This narrative review is based on a structured search of the PubMed/Medical Literature Analysis and Retrieval System Online (MEDLINE) database and relevant bibliographies (2000-2025), selecting studies that applied MRI volumetry to assess hippocampal changes after radiotherapy. We summarized the results of studies using MRI volumetry in patients undergoing radiation therapy for central nervous system tumors and nasopharyngeal cancer. The analysis covered various irradiation methods, including local and whole-brain techniques, with a focus on dose-volume relationships, temporal dynamics, and differential vulnerability of subfields. The data indicate a marked, dose-dependent reduction in hippocampal volume following irradiation. The degree of atrophy, often reaching 5-9% in the early years, significantly exceeds normal age-related decline and may rival that seen in neurodegenerative pathologies. Certain subregions, particularly the dentate gyrus and CA1, show particular sensitivity. The temporal development of atrophy varies, showing both rapid initial loss followed by stabilization and progressive patterns. The pediatric population may show partial recovery of the growth trajectory, albeit with a reduced baseline. Critical factors influencing the degree of atrophy include patient age and, potentially, neoadjuvant chemotherapy, while concurrent chemotherapy is often not a determining factor. Quantitative assessment of hippocampal volume change is a reliable and objective biomarker of radiation-induced neurotoxicity. This parameter is an important tool for refining hippocampal radiation dose constraints in radiation therapy planning and for functional assessment after treatment, highlighting the need to incorporate hippocampal protection strategies into modern neuro-oncology practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.